Key facts
- It has raised $500.0M across 3 recorded rounds; the latest was Later Stage VC (Series G) ($500.0M) in Feb 2018.
- 8 institutional filers report fund marks on Moderna across 64 filings.
- Moderna has filed 3 Form Ds with the SEC since 2013, most recently Jan 2015 ($446.1M sold to 43 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·Watchlist + deal alerts for Moderna
Create free account
No card required
Funding rounds
3 roundsFeb 2018Later Stage VC (Series G)$500.0M▮
About Moderna
- Industry
- Drug Discovery
PA Mark — not yet priced
Moderna doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Moderna shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
8 filers · latest Jun 20268 SEC-registered funds reported 64 fair-value marks on Moderna between Apr 2025 and Jun 2026. Filer-level marks and implied $/share are available to Pro members.